The study and treatment of the myelodysplastic patient

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Blood cancer journal·2016

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Leukemia & lymphoma·2016

Change in prognostic factors.

Leukemia supplements·2016

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.

Leukemia·2014

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Leukemia·2012

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Blood cancer journal·2012

Biological aging clocks as biomarkers of human aging: Biological basis, methodological design, and epidemiological implications.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

Biomarkers of the blood-brain barrier and the neurovascular unit and their relationship with cognitive decline and cognitive frailty.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

Behavioral and neuronal biomarkers of aging and disease: Integration with physical performance and function.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

Silencing of SEPT9 inhibits proliferation and migration of endometriotic stromal cells via suppression of the PI3K/AKT signaling pathway.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

Reference equations for maximal inspiratory and expiratory pressures: From childhood to advanced age.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

Precision therapeutics and innovative clinical trial design in neurodegenerative diseases.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026

Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol.

JBI evidence synthesis·2026

Factors Associated with Self-Management Behavior in Patients with Breast Cancer-Related Lymphedema.

Patient preference and adherence·2026

Clinical Outcomes of an ApoE Genotype-Guided Lipid-Lowering Strategy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.

Pharmacogenomics and personalized medicine·2026

Sensitivity and specificity of speckle tracking echocardiography for coronary artery disease: a systematic review and meta-analysis.

Frontiers in cardiovascular medicine·2026

Internationally trained physicians in family medicine leadership: Canadian cross-sectional study.

Canadian family physician Medecin de famille canadien·2026

Family-school-hospital collaboration model for urinary system tumor early screening education.

Frontiers in public health·2026

Related Experiment Videos

The study and treatment of the myelodysplastic patient

Related Concept Videos

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Change in prognostic factors.

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Biological aging clocks as biomarkers of human aging: Biological basis, methodological design, and epidemiological implications.

Biomarkers of the blood-brain barrier and the neurovascular unit and their relationship with cognitive decline and cognitive frailty.

Behavioral and neuronal biomarkers of aging and disease: Integration with physical performance and function.

Silencing of SEPT9 inhibits proliferation and migration of endometriotic stromal cells via suppression of the PI3K/AKT signaling pathway.

Reference equations for maximal inspiratory and expiratory pressures: From childhood to advanced age.

Precision therapeutics and innovative clinical trial design in neurodegenerative diseases.

Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol.

Factors Associated with Self-Management Behavior in Patients with Breast Cancer-Related Lymphedema.

Clinical Outcomes of an ApoE Genotype-Guided Lipid-Lowering Strategy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.

Sensitivity and specificity of speckle tracking echocardiography for coronary artery disease: a systematic review and meta-analysis.

Internationally trained physicians in family medicine leadership: Canadian cross-sectional study.

Family-school-hospital collaboration model for urinary system tumor early screening education.

Related Experiment Videos

The study and treatment of the myelodysplastic patient

Related Concept Videos

Related Articles